In TP53 mutant and wild-type AML treated with the pan-caspase inhibitor Q-VD-OPh, γ-H2AX was entirely lost, indicating dependence of DNA damage pathways on functional caspase activity [20]. This evidence concerns the gene TP53 and acute myeloid leukemia.